Ashwagandha-Induced Liver Injury: Self-Reports on Commercial Websites as Useful Adjunct Tools for Causality Assessment
- PMID: 34187981
- DOI: 10.14309/ajg.0000000000001369
Ashwagandha-Induced Liver Injury: Self-Reports on Commercial Websites as Useful Adjunct Tools for Causality Assessment
Comment on
-
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.Am J Gastroenterol. 2021 May 1;116(5):878-898. doi: 10.14309/ajg.0000000000001259. Am J Gastroenterol. 2021. PMID: 33929376
References
-
- Chalasani NP, Maddur H, Russo MW, et al. ACG clinical guideline: Diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol 2021;116:878–98.
-
- Weber S, Benesic A, Neumann J, et al. Liver injury associated with metamizole exposure: Features of an underestimated adverse event. Drug Saf 2021;44:669–80.
-
- Björnsson HK, Björnsson ES, Avula B, et al. Ashwagandha-induced liver injury: A case series from Iceland and the US drug-induced liver injury network. Liver Int 2020;40:825–9.
-
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Ashwagandha [database Online]. National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD; 2019. Updated May 2, 2019.
-
- NOW Supplements Ashwagandha (withania somnifera) 450 Mg (standardized extract), 90 veg capsules ( https://www.amazon.com/-/de/product-reviews/B0013OQIJY/ref=cm_cr_getr_d_... ). Accessed May 27, 2021.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical